Here are four points:
1. A rise in degenerative disease cases will drive the market’s growth.
2. Lateral lumbar interbody fusion surgery complications will present an obstacle for the market’s growth.
3. The market will see regulatory changes in device classification.
4. DePuy Synthes, Medtronic, NuVasive and Stryker lead the market.
More articles on devices:
Australian researcher creates new spinal fusion device: 6 insights
LDR Holding partners with Poly-Shape for spinal implant manufacturing: 5 points
Global hip, knee orthopedic surgical robots market to reach $5B by 2022 — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
